A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence
Megan L Ryan, Daniel E Falk, Joanne B Fertig, Beatrice Rendenbach-Mueller, David A Katz, Katherine A Tracy, Eric C Strain, Kelly E Dunn, Kyle Kampman, Elizabeth Mahoney, Domenic A Ciraulo, Laurie Sickles-Colaneri, Nassima Ait-Daoud, Bankole A Johnson, Janet Ransom, Charles Scott, George F Koob and Raye Z Litten for the National Institute on Alcohol Abuse and Alcoholism Clinical Investigations Group (NCIG) Study Group
Binge-Like Alcohol Exposure During Adolescence Disrupts Dopaminergic Neurotransmission in the Adult Prelimbic Cortex OPEN
Heather Trantham-Davidson, Samuel W Centanni, S Corrin Garr, Natasha N New, Patrick J Mulholland, Justin T Gass, Elizabeth J Glover, Stan B Floresco, Fulton T Crews, Harish R Krishnan, Subhash C Pandey and L Judson Chandler
Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence OPEN
Anna Murphy, Liam J Nestor, John McGonigle, Louise Paterson, Venkataramana Boyapati, Karen D Ersche, Remy Flechais, Shankar Kuchibatla, Antonio Metastasio, Csaba Orban, Filippo Passetti, Laurence Reed, Dana Smith, John Suckling, Eleanor Taylor, Trevor W Robbins, Anne Lingford-Hughes, David J Nutt, John FW Deakin and Rebecca Elliott ICCAM Platform
Differential Roles for L-Type Calcium Channel Subtypes in Alcohol Dependence
Stefanie Uhrig, David Vandael, Andrea Marcantoni, Nina Dedic, Ainhoa Bilbao, Miriam A Vogt, Natalie Hirth, Laura Broccoli, Rick E Bernardi, Kai Schönig, Peter Gass, Dusan Bartsch, Rainer Spanagel, Jan M Deussing, Wolfgang H Sommer, Emilio Carbone and Anita C Hansson
Specific Inhibition of Phosphodiesterase-4B Results in Anxiolysis and Facilitates Memory Acquisition
Alexander McGirr, Tatiana V Lipina, Ho-Suk Mun, John Georgiou, Ahmed H Al-Amri, Enoch Ng, Dongxu Zhai, Christina Elliott, Ryan T Cameron, Jonathan GL Mullins, Fang Liu, George S Baillie, Steven J Clapcote and John C Roder
Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription.
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).